The server is under maintenance between 08:00 to 12:00 (GMT+08:00), and please visit later.
We apologize for any inconvenience caused
Login  | Sign Up  |  Oriprobe Inc. Feed
China/Asia On Demand
Journal Articles
Laws/Policies/Regulations
Companies/Products
Bookmark and Share
wan qi gan ai lin chuang shi yan ru zu biao zhun tan tao
Author(s): 
Pages: 4351-4352
Year: Issue:  24
Journal: The Journal of Practical Medicine

Abstract:  原发性肝细胞癌(hepatocelluar carcinoma,HCC)是世界上最常见、恶性程度最高的肿瘤之一.发病率在恶性肿瘤中位居全球第5位,病死率位居第3位[1-2].西方30%~40%的肝癌患者没有根治性局部治疗机会[3],中国有90%的患者没有根治性手术机会[4].同时,原发性肝细胞性肝癌经过根治性局部治疗后有较高的复发率[1,5-6].因此大部分肝癌患者需要接受全身治疗.
Related Articles
No related articles found